Experiment 67722

Worktypes

Details

PropertyValue
Pharmacology
Administration routeSC
OrganismViscum album (LORANTHACEAE)
CitationSTEUER VOGT,MK: BONKOWSKY,V: AMBROSCH,P: SCHOLZ,M: NEIB,A: STRUTZ,J: HENNIG,M: LENARZ,T: ARNOLD,W:. (2001). THE EFFECT OF AN ADJUVANT MISTLETOE TREATMENT PROGRAMME IN RESECTED HEAD AND NECK CANCER PATIENTS: A RANDOMISED CONTROLLED CLINICAL TRIAL.. 37(1)
Amount utilized
Compound isolated
DiseaseTHE EFFECT OF AN ADJUVANT MISTLETOE EXTRACT TREATMENT WAS TESTED IN A PROSPECTIVE, RANDOMISED CONTROLLED CLINICAL TRIAL INVOLVING 477 PATIENTS WITH HEAD AND NECK SQUAMOUS CELL CARCINOMA. THE PATIENTS WERE STRATIFIED INTO TWO TREATMENT GROUPS THAT UNDERWENT SURGERY OR SURGERY FOLLOWED BY RADIOTHERAPY AND BOTH GROUPS WERE RANDOMISED FOR ADDITIONAL TREATMENT WITH MISTLETOE EXTRACT. PATIENTS TREATED WITH A MISTLETOE LECTIN-1 (ML-1) STANDARDISED MISTLETOE PREPARATION HAD NO LOWER RISK OF LOCAL/LOCOREGIONAL RECURRENCES, DISTANT METASTASES OR SECOND PRIMARIES. THE 5-YEAR SURVIVAL RATES OF PATIENTS FROM THE MISTLETOE GROUP WERE NO BETTER THAN THE SURVIVAL RATES OF PATIENTS FROM THE CONTROL GROUP.
Dose amount1.0 NG
Number1
Qualitative resultINACTIVE
AnimalHUMAN ADULT
Per unitKG
Dose expressionDOSE
ExtractTYPE EXT NOT STATED
GenderGIVEN TO BOTH SEXES